Rentschler focuses on biotechnology
17 July 2008
Rentschler will invest another €14
million in the expansion of Rentschler Biotechnologie GmbH at its
Laupheim, Germany site. The company has recently has recently completed
a €50m investment in
biotechnological development and production facilities.
Work will start later this year for the new construction of a
logistics centre and the expansion of the administrative building in
Erwin-Rentschler-Straße in Laupheim. In the logistics centre, a
high-rise warehouse, several cold warehouses, an incoming goods
department, a dispatch area and the company's transport fleet will be
The move into the new buildings is planned for end of 2009. This step
will concentrate all of Rentschler's biotech activities at one site and
thus provides the frame for further growth.
Within the scope of this business concentration on the development
and manufacture of biopharmaceutical drug products, Dr Rentschler
Holding GmbH & Co. KG has sold all of the shares of Rentschler Pharma
GmbH to Riemser Arzneimittel AG in Greifswald/Isle of Riems, Eastern
Riemser is planning to further expand its business division contract
manufacture from the Laupheim site. In this connection Rentschler Pharma
GmbH will be renamed to Riemser Speciality Production GmbH.